MedTrace Logo

Mass Balance Study of [14C]HLX208 in China Healthy Subjects

NCT05841940 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2024-01-16

No results posted yet for this study

Summary

Mass Balance Study of \[14C\]HLX208 in China Healthy Subjects.

Conditions

  • Mass Balance Study in Healthy Subjects

Interventions

DRUG

[14C]HLX208

Carbon-14 labeled HLX208

Sponsors & Collaborators

Principal Investigators

  • Liyan Miao, Dr. · The First Affiliated Hospital of Soochow University

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-06-17
Primary Completion
2023-07-15
Completion
2023-12-15

Countries

  • China

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05841940 on ClinicalTrials.gov